Evansbrook LLC Makes New $640,000 Investment in CME Group Inc. $CME

Evansbrook LLC purchased a new position in CME Group Inc. (NASDAQ:CME) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 2,342 shares of the financial services provider’s stock, valued at approximately $640,000.

Several other institutional investors and hedge funds have also recently made changes to their positions in CME. West Family Investments Inc. grew its position in CME Group by 1.2% in the third quarter. West Family Investments Inc. now owns 3,062 shares of the financial services provider’s stock worth $827,000 after acquiring an additional 37 shares in the last quarter. Asset Dedication LLC raised its position in CME Group by 64.9% during the fourth quarter. Asset Dedication LLC now owns 94 shares of the financial services provider’s stock valued at $26,000 after purchasing an additional 37 shares in the last quarter. Northwestern Mutual Investment Management Company LLC raised its position in CME Group by 0.3% during the fourth quarter. Northwestern Mutual Investment Management Company LLC now owns 11,523 shares of the financial services provider’s stock valued at $3,147,000 after purchasing an additional 37 shares in the last quarter. Rehmann Capital Advisory Group lifted its stake in CME Group by 4.3% during the third quarter. Rehmann Capital Advisory Group now owns 898 shares of the financial services provider’s stock worth $243,000 after purchasing an additional 37 shares during the last quarter. Finally, 1248 Management LLC lifted its stake in CME Group by 26.8% during the third quarter. 1248 Management LLC now owns 180 shares of the financial services provider’s stock worth $49,000 after purchasing an additional 38 shares during the last quarter. Hedge funds and other institutional investors own 87.75% of the company’s stock.

Analyst Ratings Changes

Several equities analysts have recently commented on the company. JPMorgan Chase & Co. increased their price objective on CME Group from $266.00 to $271.00 and gave the company an “underweight” rating in a research report on Thursday, April 16th. UBS Group reaffirmed an “overweight” rating on shares of CME Group in a research note on Monday. Argus reiterated a “hold” rating on shares of CME Group in a research report on Wednesday, March 4th. Deutsche Bank Aktiengesellschaft reduced their price target on shares of CME Group from $342.00 to $322.00 and set a “buy” rating on the stock in a research report on Thursday, April 23rd. Finally, Rothschild & Co Redburn raised shares of CME Group from a “neutral” rating to a “buy” rating and lifted their price target for the stock from $316.00 to $323.00 in a research note on Thursday, June 11th. Twelve research analysts have rated the stock with a Buy rating, four have given a Hold rating and two have assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, CME Group presently has a consensus rating of “Moderate Buy” and a consensus target price of $305.18.

Insider Transactions at CME Group

In other news, insider Hilda Harris Piell sold 5,753 shares of the stock in a transaction dated Monday, May 18th. The shares were sold at an average price of $304.63, for a total transaction of $1,752,536.39. Following the completion of the sale, the insider directly owned 27,702 shares in the company, valued at approximately $8,438,860.26. This represents a 17.20% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO Terrence A. Duffy sold 35,000 shares of the firm’s stock in a transaction dated Friday, May 15th. The stock was sold at an average price of $298.51, for a total value of $10,447,850.00. Following the completion of the sale, the chief executive officer directly owned 55,630 shares in the company, valued at $16,606,111.30. The trade was a 38.62% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 0.30% of the stock is currently owned by insiders.

Key Stories Impacting CME Group

Here are the key news stories impacting CME Group this week:

• Neutral Sentiment: CME announced a planned CEO succession: longtime chief Terry Duffy will step down in March 2027 and transition to executive chairman, while President and CFO Lynne Fitzpatrick will become CEO. The move also makes Fitzpatrick CME’s first woman chief executive, which supports continuity but adds some near-term uncertainty around the handoff. Article Title
• Neutral Sentiment: The company also highlighted its long-term leadership change in multiple interviews and reports, which may reassure investors that the transition is orderly rather than sudden. Article Title
• Negative Sentiment: CME said it plans to sue the CFTC over approval of crypto perpetual futures, arguing the regulator is improperly treating these products as swaps rather than futures. The legal fight raises regulatory risk and could create uncertainty around CME’s crypto derivatives strategy. Article Title
• Negative Sentiment: Several headlines repeated the lawsuit plan, suggesting the issue is the main driver of today’s weakness as investors focus on possible friction with regulators and the implications for future product approvals. Article Title

CME Group Stock Down 2.4%

Shares of CME Group stock opened at $246.38 on Friday. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.02 and a current ratio of 1.02. CME Group Inc. has a 52-week low of $244.56 and a 52-week high of $329.16. The stock has a market capitalization of $89.28 billion, a price-to-earnings ratio of 21.02, a P/E/G ratio of 2.82 and a beta of 0.21. The company’s 50 day moving average price is $280.74 and its 200-day moving average price is $287.50.

CME Group (NASDAQ:CME) last posted its quarterly earnings results on Wednesday, April 22nd. The financial services provider reported $3.36 EPS for the quarter, beating analysts’ consensus estimates of $3.11 by $0.25. The company had revenue of $1.88 billion during the quarter, compared to analyst estimates of $1.77 billion. CME Group had a net margin of 63.19% and a return on equity of 15.42%. The firm’s revenue was up 14.5% compared to the same quarter last year. During the same period in the prior year, the business posted $2.80 EPS. Equities research analysts forecast that CME Group Inc. will post 12.28 EPS for the current year.

CME Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, June 25th. Shareholders of record on Tuesday, June 9th will be given a $1.30 dividend. The ex-dividend date is Tuesday, June 9th. This represents a $5.20 dividend on an annualized basis and a dividend yield of 2.1%. CME Group’s payout ratio is presently 44.37%.

About CME Group

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.